Analytical performance of a standardized single‐platform MHC tetramer assay for the identification and enumeration of CMV‐specific CD8+ T lymphocytes
Open Access
- 22 October 2008
- journal article
- research article
- Published by Wiley in Cytometry Part A
- Vol. 73A (11) , 992-1000
- https://doi.org/10.1002/cyto.a.20641
Abstract
Major histocompatibility complex (MHC) multimers that identify antigen-specific T cells, coupled with flow cytometry, have made a major impact on immunological research. HLA Class I multimers detect T cells directed against viral, tumor, and transplantation antigens with exquisite sensitivity. This technique has become an important standard for the quantification of a T cell immune response. The utility of this method in multicenter studies, however, is dependant on reproducibility between laboratories. As part of a clinical study using a standardized two-tube three-color single-platform method, we monitored and characterized performance across multiple sites using tetramers against the T cell receptors (TCR) specific for MHC Class I, A*0101—VTEHDTLLY, A*0201—NLVPMVATV and B*0702—TPRVTGGGAM CMV peptides. We studied the analytical performance of this method, focusing on reducing background, maximizing signal intensity, and ensuring that sufficient cells are enumerated to provide meaningful statistics. Inter and intra-assay performance were assessed, which included inherent variability introduced by shipping, type of flow cytometer used, protocol adherence, and analytical interpretation across a range of multiple sample levels and specificities under routine laboratory testing conditions. Using the described protocol, it is possible to obtain intra- and interlab CV's of <20%, with a functional sensitivity for absolute tetramer counts of 1 cell/μL and 0.2% tetramer+ percent for A*0101, A*0201, and B*0702 alleles. The standardized single-platform MHC tetramer assay is simple, rapid, reproducible, and useful for assessing CMV-specific T cells, and will allow for reasonable comparisons of clinical evaluations across multiple centers at clinically relevant thresholds (2.0–10.0 cells/μL). © 2008 International Society for Advancement of CytometryKeywords
This publication has 47 references indexed in Scilit:
- Proliferative, IFNγ and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infectionAIDS, 2006
- Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancerTrends in Immunology, 2005
- MHC multimer technology: current status and future prospectsCurrent Opinion in Immunology, 2005
- The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognitionNature Immunology, 2005
- Enumeration of antigen‐specific CD8+ T lymphocytes by single‐platform, HLA tetramer‐based flow cytometry: A European multicenter evaluationCytometry Part B: Clinical Cytometry, 2004
- Impaired recovery of Epstein-Barr virus (EBV)—specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative diseaseBlood, 2003
- Reduction of variation in T‐cell subset enumeration among 55 laboratories using single‐platform, three or four‐color flow cytometry based on CD45 and SSC‐based gating of lymphocytesCytometry, 2002
- Tracking T cells with tetramers: new tales from new toolsNature Reviews Immunology, 2002
- Establishment and Persistence of Virus‐Specific CD4+ and CD8+ T Cell MemoryImmunological Reviews, 1996
- The Human T-Cell ReceptorAnnual Review of Immunology, 1984